Chronic kidney disease in Polish elderly population aged 75+ : results of the WOBASZ Senior Survey by Zdrojewski, Łukasz et al.
1 3
Int Urol Nephrol (2017) 49:669–676
DOI 10.1007/s11255-016-1477-7
NEPHROLOGY - ORIGINAL PAPER
Chronic kidney disease in Polish elderly population aged 75+: 
results of the WOBASZ Senior Survey
Łukasz Zdrojewski1 · Ewa Król1 · Bolesław Rutkowski1 · Walerian Piotrowski2 · 
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participants was found to be at 17%. Arterial hyperten-
sion (AH) was more frequent in people with CKD (91.0 
vs. 80.3%, P < 0.001), whereas diabetes mellitus (DM) 
prevalence was comparable in both CKD and non-CKD 
groups (11.7 vs. 11.4%, ns). In the examined group, DM 
had no influence on the frequency of CKD. In contrast, 
the presence of cardiovascular diseases substantially 
increased the chances of developing CKD (OR 1.87, 
P < 0.05).
Conclusion 1. The prevalence of CKD in the Polish elderly 
population was 26.9%. 2. Awareness of CKD is low. 3. 
DM, increasing age and AH did not increase the risk of 
CKD. 4. Coexistence of cardiovascular diseases increased 
the risk of having CKD.
Keywords Chronic kidney disease · Population survey · 
Elderly · eGFR · Diabetes · Hypertension · Cardiovascular 
disease
Introduction
Chronic kidney disease (CKD) is a disease characterized 
by a decrease in renal filtration function and/or damage to 
the kidney structure. This disease was precisely defined in 
guidelines published in 2012 by the international group, 
“Kidney Disease—Improving Global Outcome (KDIGO) 
[1]”. This revised definition includes the previously known 
criteria which divided CKD into five stages of disease pro-
gression, based on the estimated value of glomerular filtra-
tion rate (eGFR), additionally appended with the level of 
albuminuria intensity. The severity of CKD assessed in this 
manner is therefore linked to the risk of progression to end-
stage renal disease, as well as occurrence of cardiovascular 
complications [2, 3].
Abstract 
Purpose Kidney filtration decreases with age, which 
results in an increased frequency of chronic kidney disease 
(CKD) in the elderly population. The purpose of the study 
was to assess the prevalence and epidemiology of CKD in 
the Polish elderly population.
Methods A representative sample of the Polish elderly pop-
ulation, composed of 918 people (F 452, M 466) in the age 
of ≥75 years, was chosen. All participants had their history, 
anthropometric measures and biochemical parameters (cre-
atinine, fasting glucose, complete cholesterol) evaluated. 
CKD was diagnosed when eGFR was <60 ml/min/1.73 m2. 
The comorbidities, anthropometric and social factors con-
nected with the onset of CKD were also analyzed.
Results The prevalence of CKD in the analyzed popu-
lation was 26.9% (F 32.0%, M 15.8%), which gives an 
estimated number of 495,590 (95% CI 396,363–594,817) 
patients in the study subpopulation. The majority of 
these people were in the G3A category—70.1%, while 
the remaining fell under the G3B—25.7%, G4—3.1% 
and G5—1.1% categories. Disease awareness among the 
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Based on previous population studies, it has been shown 
that the frequency of CKD prevalence increases with age 
[4, 5]. It has also been proven that in the population of 
elderly people, the prevalence is high and reaches 19–29% 
in European and American populations [6–10]. How-
ever, there is still a fierce discussion on whether the high 
prevalence of CKD in the elderly population is indeed a 
pathological state or a result of the general physiological 
aging of the organism. What is more, the traditional cri-
teria of CKD diagnosis and classification based on eGFR 
values are calculated on the basis of formulae not validated 
for the discussed population; therefore, it does not take 
into account neither the physiological changes connected 
with aging nor pathologies of elderly, such as sarcopenia 
or frailty syndrome. Taking the above into consideration, 
there is an ongoing discussion on whether it is legitimate to 
apply the same diagnostic criteria for elderly people as that 
of the remaining younger part of the population [11]. Anal-
ysis of epidemiological studies may be helpful in finding an 
answer to this question. Therefore, the aim of this paper is 
to assess the prevalence of CKD in the Polish population of 
elderly people of 75 years and above, who took part in the 
WOBASZ Senior Survey.
Methods
The WOBASZ Senior Survey is a cross-sectional survey 
conducted on a representative sample of Polish people in 
the age of ≥75 years. The primary objective of the sur-
vey was the assessment of cardiovascular diseases in this 
population [12]. A two-staged sampling scheme was used, 
stratified according to provincial and district categories (2 
small districts, 2 medium and 2 large districts from every 
province). In the first stage, streets (in municipalities) or 
villages (in communes) were drawn. In the second stage 
of sampling, people who met the sex and age criteria were 
drawn from those registered in given streets or villages. The 
sample size was selected in proportion to the percentage of 
the Polish population aged ≥75. The draw was conducted 
in the Department of National Registers at the Ministry of 
Internal Affairs and Administration (MSWiA). A total of 
1070 men and 1084 women were drawn. After verifica-
tion (having subtracted those unavailable for the study), the 
final sample was 755 men and 704 women. 508 men and 
502 women gave their written consent for the participation 
in the study. The final response rate was 67.3% among men 
and 71.3% among women. Comprehensive results which 
included a questionnaire, laboratory results and anthropo-
metric measurements were obtained from 918 people (F 
452, M 466). The study, which consisted of taking medi-
cal history, answering a sociodemographic questionnaire, 
anthropometric measurements and blood sample collection 
was conducted by trained research teams in accordance 
with the protocol prepared by the regulatory team. Labora-
tory tests were performed in a central laboratory with inter-
national standardization. Serum creatinine concentration 
was measured using reagents from the Roche Company 
through the Jaffe buffer kinetic method on the Integra 800 
analyzer.
Renal function was determined using eGFR and cal-
culated using the simplified MDRD equation (MDRD4) 
[13–15]. CKD was diagnosed when eGFR was lower than 
60 mL/min/1.73 m2. A simplified division of CKD into 
stages was applied, leaving out G1 and G2 stages. Stages 
G3a (eGFR 45–59 mL/min/1.73 m2), G3b (30–44), G4 
(15–29), G5 (<15) were diagnosed, in correspondence with 
the former definition of chronic kidney failure [1, 16].
Diabetes mellitus (DM) was noted when a patient 
declared that it had been previously diagnosed or if fast-
ing glucose was ≥126 mg/dL. The respondent was diag-
nosed with arterial hypertension (AH) when one declared 
regular intake of hypotensive drugs or when the average 
value of two arterial blood pressure measurements taken 
at two separate visits was ≥140/90 mmHg. Additional 
information concerning the coexistence of other diseases, 
awareness of kidney disease, proteinuria, nocturia, socio-
economic status and the respondent’s educational status 
was obtained through the use of a questionnaire. Statisti-
cal weights were applied to improve adjustment of the age 
and sex structure of the study population to match that of 
the general population aged ≥75 years, on the basis of data 
published by the Central Statistical Office. Statistical anal-
ysis was performed using IBM SPSS statistics version 19, 
Complex Samples Module software. Statistical significance 
was established by Chi-squared test, and logistic regression 
analysis was used to establish confidence intervals (CIs) 
and odds ratios (ORs).
Results
Chronic kidney disease
The average age of the examined population was: men 
(M) 78.9 years, women (F) 79.2. Successively, the aver-
age age of the group diagnosed with CKD was 80.5 
(M) and 80.1 (F). Using the above-mentioned diagnos-
tic criteria, chronic kidney disease with eGFR < 60 mL/
min/1.73 m2 (≥G3a) was diagnosed in 196 people (129 F, 
67 M). In the 75–79 years subgroup, there were 111 peo-
ple, 80–84 years—60 people, 85–89 years—21 people, 
and in the 90+ group they were 4 people. After extrapolat-
ing these results to the Polish population with a use of the 
above-mentioned methods, the prevalence of CKD in those 
aged 75+ was 26.9%, with a higher prevalence in women 
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(32.0%) than in men (15.8%), P < 0.001 (Table 1). A sub-
sequent increase in the incidence of CKD was observed 
with increase in age: in the interval 75–79 years—24.2% 
(F 29.6%; M 14.4%), 80–84 years—29.4% (F 34.1%; 
M 15.2%), 85–89 years—30.4% (F 35.3%; M 21.2%), 
≥90 years—37.2% (F unknown; M 31.4%).
We also evaluated the incidence of the various CKD 
stages in the population of elderly people. The major-
ity of people diagnosed with CKD were in the G3A cat-
egory—70.1%, while the remaining population fell under 
the G3B—25.7%, G4—3.1% and G5—1.1% categories 
(Table 2). In summary, based on the results above, it can be 
assumed that in the Polish population aged 75+, approxi-
mately 495,590 (95% CI 396,363–594,817) people met the 
criteria for diagnosis of chronic kidney disease.
The awareness of kidney disease was relatively low in 
the study population. Only 17.0% (95% CI 10.4–26.5) of 
the population aged 75+ was aware of this ailment. This 
percentage was slightly higher in women (17.6%) than 
in men (15.4%), but the difference was not statistically 
significant.
Coexisting diseases
Among diseases that most often coexist with CKD and 
simultaneously are the most often primal cause of progres-
sive kidney function loss in the general population are arte-
rial hypertension and diabetes. Epidemiology of the coex-
istence of these pathological states with CKD in the Polish 
population aged 18–79 years has been previously described 
[5]. Among the studied group in the age of ≥75 years, high 
prevalence of arterial hypertension (AH) was remarkable, 
both in people with normal and impaired kidney function 
(Table 3). In people with eGFR > 60 mL/min/1.73 m2, 
80.3% had AH, whereas in those with eGFR < 60 mL/
min/1.73 m2 AH was found in 91.0% (P < 0.001). In both 
groups, AH was more frequent in women, but these dif-
ferences were not statistically significant (F 84.2% and M 
73.6% vs. F 93.1% and M 82.0%). In contrast, a low preva-
lence of DM was observed in both people with normal and 
impaired kidney function. In people with eGFR > 60 mL/
min/1.73 m2, DM was diagnosed in 11.4%, and in those 
with an eGFR < 60 mL/min/1.73 m2, DM was found in a 
similar percentage of people—11.7% (a statistically insig-
nificant difference). Among diabetic patients, those with 
normal kidney function were predominantly males (F 10.8 
vs. M 13.7%), whereas in the group with lower eGFR there 
was a higher percentage of women (F 13.3 vs. M 9.0%); 
however, statistical significance was again not demon-
strated (Table 3).
Risk factors
The results of multivariate logistic regression analysis in 
the population aged ≥75 years differ from those obtained 
from younger populations for selected classical risk fac-
tors of CKD (Table 4). Clearly, increasing age is one of the 
major risk factors of kidney failure, yet in the population 
Table 1  CKD prevalence 
(eGFR < 60 ml/min/1.73 m2) 
in polish elderly population 
≥75 standardized to resident 
population depending on 
applied diagnostic criteria
WOBASZ Senior: general population of the study: 918 (F 452, M 466), CKD population: 196 (F 129, M 
67), age ≥75, MDRD4 eGFR (mL/min/1.73 m2)
F female, M male
Age (years) Prevalence of eGFR < 60 mL/min/1.73 m2
>75 (the studied 
population)
75–79 80–84 85–89 >90
% 95% CI % 95% CI % 95% CI % 95% CI % 95% CI
F + M 26.9 23.1–30.9 24.2 20.2–28.7 29.4 23.2–36.5 30.4 21.5–41.2 37.2 9.7–76.5
F 32.0 27.7–36.7 29.6 24.6–35.1 34.1 26.5–42.6 35.3 23.0–49.8
M 15.8 10.4–23.4 14.4 8.2–24.0 15.2 8.4–26.2 21.2 11.5–35.8 31.4 5.7–77.5
Table 2  Percentage distribution 
of the diseased into CKD stages
WOBASZ Senior: general population of the study: 918 (F 452, M 466), CKD population: 196 (F 129, M 
67), age ≥75, MDRD4 eGFR (mL/min/1.73 m2)
CKD stage eGFR range value Age group (%), (95% CI)
≥75 75–84 ≥85
G3A 60–45 70.1 (59.0–79.2) 64.5 (53.1–74.4) 5.6 (2.8–11.0)
G3B 44–30 25.7 (17.0–36.8) 19.4 (11.6–30.5) 6.3 (3.0–12.6)
G4 29–15 3.1 (1.4–6.6) 2.4 (1.0–5.8) 0.7 (0.2–2.8)
G5 ≤14 1.1 (0.2–5.6) 1.1 (0.2–5.6) –
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in question, it was not as strong a factor as in younger 
populations. It was not proven that there exists any sta-
tistical significance of increased odds ratios for decreased 
kidney function and the coexistence of arterial hyperten-
sion, as well as increasing values of systolic, diastolic 
nor mean arterial pressure. The indisputable relationship 
between AH and CKD observed in younger cohorts [5] 
was only suggested in the studied population (odds ratio 
OR 1.5, P > 0.05). It was also surprising to observe the 
lack of impact of coexisting DM on CKD prevalence. It 
was, however, noticed that the risk is increased by the 
presence of cardiovascular diseases (coronary heart dis-
ease, heart failure, peripheral arteries disease, stroke—OR 
1.87, P < 0.05). The results also seemed to suggest a posi-
tive role of an increased waist-to-hip ratio (WtHR) value, 
although no such link was found for body mass index 
(BMI). Furthermore, among people with reduced eGFR, 
normal body mass (BMI 18.5–24.9 kg/m2) was less fre-
quently observed, while obesity (BMI > 30 kg/m2) was 
more frequent in comparison with people with normal 
eGFR (Table 3).
CKD prevalence in the studied population was higher 
in women, and female gender seemed to increase the 
chances of disease occurrence, though it was not a sta-
tistically significant result. In addition, a few risk factors 
Table 3  Characteristics of CKD and non-CKD populations
WOBASZ Senior: general population of the study: 918 (F 452, M 466), CKD population: 196 (F 129, M 67), age ≥75, MDRD4 eGFR (ml/
min/1.73 m2)
F female, M male, BMI body mass index (kg/m2), WtHR waist-to-hip ratio, increased WtHR: M > 0.9, K > 0.85, increased total cholesterol 
>190 mg/dl; increased LDL > 115 mg/dl
Parameter eGFR > 60 mL/min/1.73 m2 eGFR < 60 mL/min/1.73 m2
F + M F M F + M F M
Hypertension prevalence (%), 
(95% CI)
80.3 (76.5–83.7) 84.2 (78.5–88.6) 73.6 (68.4–78.3) 91.0 (86.4–94.1) 93.1 (87.4–96.3) 82.0 (72.2–88.8)
Diabetes mellitus prevalence 
(%), (95% CI)
11.4 (7.7–16.6) 10.8 (6.6–17.2) 13.7 (8.3–21.8) 11.7 (7.4–18.0) 13.3 (7.1–23.5) 9.0 (6.5–12.3)
BMI, mean value (kg/m2), (95% 
CI)
27.6 (27.0–28.2) 27.9 (27.1–28.8) 27.1 (26.4–27.8) 29.6 (28.8–30.4) 30.0 (29.1–30.9) 27.7 (26.4–27.8)
BMI (%), (95% CI)
 18.50–24.99 31,7 (27.5–36.3) 29,5 (23.7–36.0) 35,6 (30.3–41.3) 19,8 (14.1–27.2) 17,5 (10.9–26.8) 30,0 (22.4–38.9)
 25.00–29.99 41.3 (36.2–46.7) 42.1 (34.7–49.8) 40.0 (34.3–46.0) 33.8 (26.2–42.2) 31.7 (22.9–42.1) 33.8 (26.2–42.2)
 ≥30 27.0 (22.1–32.5) 28.4 (21.4–36.7) 24.4 (19.3–30.4) 46.4 (39.4–53.6) 50.8 (42.2–59.3) 27.4 (19.5–37.0)
WtHR, mean value (95% CI) 0.90 (0.88–0.91) 0.87 (0.85–0.87) 0.96 (0.95–0.97) 0.90 (0.87–0.92) 0.89 (0.86–0.92) 0.93 (0.87–0.98)
WtHR increased (%), (95% CI) 67.1 (61.7–72.1) 61.2 (53.5–68.4) 67.1 (61.7–72.1) 67.4 (49.7–81.2) 65.2 (43.9–81.8) 76.5 (68.7–83.0)
Total cholesterol, mean value 
(mg/dl), (95% CI)
200 (196–204) 206 (200–212) 190 (186–194) 207 (201–213) 208 (202–215) 202 (192–211)
Total cholesterol, increased (%), 
(95% CI)
58.8 (53.6–63.8) 65.6 (57.8–72.5) 47.1 (41.4–52.9) 61.3 (54.2–68.0) 61.4 (53.0–69.2) 60.7 (54.2–68.0)
LDL, mean value (mg/dl), (95% 
CI)
129 (125–133) 132 (126–138) 124 (121–128) 133 (128–138) 133 (127–140) 132 (121–142)
LDL increased, (%) (95% CI) 65.4 (60.3–70.2) 68.0 (60.3–74.8) 61.0 (60.3–70.2) 64.4 (56.4–71.6) 63.9 (54.4–72.4) 66.4 (55.2–76.1)
Table 4  Multivariate logistic regression analysis estimating corre-
lates of CKD
WOBASZ Senior: general population of the study: 918 (F 452, M 
466); CKD population: 196 (F 129, M 67); age ≥75
F female, M male, BMI body mass index (kg/m2), WtHR waist-to-hip 
ratio, SBP, DBP, MBP systolic, diastolic, mean blood pressure; edu-
cation other versus university
Bold letters—statistically significant
Variable eGFR < 60 mL/min/1.73 m2
Odds ratio 95% CI P
Age, rising 1.08 1.02–1.14 0.012
Hypertension 1.50 0.87–2.56 0.140
Diabetes mellitus 0.67 0.31–1.43 0.296
Sex: F versus M 1.97 0.87–4.49 0.105
Cardiovascular disease 1.87 1.15–3.03 0.011
Smoking 0.84 0.37–1.96 0.694
SBP 0.99 0.98–1.00 0.054
DBP 1.02 0.99–1.04 0.219
MBP 0.99 0.98–1.01 0.373
BMI, rising 0.97 0.93–1.03 0.357
WtHR, rising 0.13 0.00–0.66 0.031
LDL 0.95 0.40–2.26 0.915
Education 1.14 0.44–2.91 0.790
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which are usually analyzed in CKD population surveys, 
such as nicotinism or education level, proved to play no 
vital role.
Discussion
Along with aging of European societies, common attention 
is paid to chronic diseases whose prevalence increases in 
the elderly, especially when their course is connected with 
deterioration of the quality of life, increase in mortality due 
to cardiovascular reasons and necessity of increasing finan-
cial expenses for medical care. It has been well demon-
strated that there is a significant connection between CKD 
and the frequency of cardiovascular diseases and increased 
cardiovascular mortality in the general population, as well 
as in the elderly population [3, 17–21]. This fact seems to 
be the best, albeit indirect, answer to the voices questioning 
the validity of diagnosing CKD in elderly people. Being 
aware of the technical limits of eGFR estimation and the 
exceptions in the physiology of old age, the diagnosis of 
CKD that is made by a physician should be followed by the 
introduction of proper medical care and nephroprotective 
treatment. Epidemiological studies help in characterizing 
the group which will benefit the most from such a conduct. 
However, thus far, we have not had a lot of scientific data 
concerning CKD prevalence in elderly people in Poland. 
Our knowledge of this issue has been so far shaped by the 
results of the Polnef Study carried out in the Pomeranian 
region and published a few years ago, results of the nation-
wide Polsenior survey, as well as foreign surveys which are 
mostly American [6, 17, 22]. It is worth noting that a sig-
nificant increase in CKD prevalence in elderly people was 
observed in the recently published NATPOL 2011 survey 
[5].
An essential advantage of this article is that we elabo-
rate on and present results of a large epidemiological sur-
vey, which had a very advanced methodology of sampling, 
ensuring representativeness of the survey results for the 
Polish elderly population aged ≥75.
In our study, we have shown a very high CKD preva-
lence in the population in question (26.9%), which is 
consistent with earlier reports. Among the data presented 
by other authors, CKD prevalence varies from 21 to as 
much as 50%, depending on the methodology used and 
the precise age ranges. The authors of the Polsenior sur-
vey reported a slightly lower average value of decreased 
eGFR < 60 ml/min/1.73 m2 frequency (21.2%). However, 
the estimated incidence of CKD in the above-mentioned 
study was 29.4%, which may be as a result of it encom-
passing a younger group of respondents (≥65) and simul-
taneously taking into account assessment of albuminuria in 
the survey protocol [6].
We also assessed the awareness of participants regard-
ing the prevalence of kidney disease. The obtained result 
of 17%, though generally low, is still higher than the one 
reported by the authors of the Polsenior survey, and even 
slightly higher than the one established in younger popu-
lations in the NATPOL 2011 survey. This may be due to 
Poles having relatively good accessibility to health ser-
vices, and the educational and prophylactic role of basic 
health care. On the other hand, the elderly are characterized 
by relatively greater interest and concern for their health 
than younger people.
In the analysis of the percentage representation of the 
respective stages of CKD, special attention should be paid 
to the G3a category which is the predominant category and 
also raises the biggest controversies. Some authors doubt the 
clinical significance of diagnosing G3a stage CKD based 
on moderately lowered eGFR [23]. Moreover, as shown by 
Stengel et al. [24], there is a stronger connection between 
the G3b stage (in comparison with G3a) and cardiovascular 
diseases and deaths observed. As it has been established in 
earlier studies, we can observe a nonlinear decrease in eGFR 
values by, on average, 10 ml/min/1.73 m2 in a decade of life 
[4]. Therefore, it is possible that in the 75+ age group there 
are individuals in whom the decrease in eGFR to the level 
meeting CKD diagnosis results from the physiological aging 
of kidneys and is not a symptom of pathology. Thus, the 
debate concerning a possible lowering of the CKD diagnosis 
level in old age to the value of eGFR < 45 ml/min/1.73 m2, 
especially in situations where there are no other kidney dam-
age markers, still remains open [25]. In our analysis, for 
example, it would mean a significant drop in the estimated 
number of CKD patients in the population from 495,590 to 
148,356 people. At the moment, however, the opinion men-
tioned in the introduction of this article dominates—i.e., the 
definition and division of CKD is firmly supported by pre-
vailing data, and the presented evidence is not sufficient to 
create a separate classification for the elderly population. 
Furthermore, elderly people can only benefit from improved 
care, prophylaxes and treatment that should follow the 
implementation of the current criteria [11].
In order to reaffirm the adequacy of the data presented 
in this study, the cited estimations were compared with the 
available data from the registry based on the actual num-
ber of patients in end-stage CKD. In the G5 category, there 
were up to 1.1% of all patients with CKD, which approx-
imately gives a group of 5451 patients in end-stage renal 
disease. From the article “The report on the state of renal 
replacement therapy in Poland”, in 2007 exactly 958 
patients in the age of ≥75 years started renal replacement 
therapy (RRT). Thus, the estimated number of patients in 
the G5 stage seems probable, as approximately 1/5 of the 
projected number entered the renal replacement therapy 
(RRT) program. It should be taken into account, that in 
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the age range in question, there is nowadays a tendency 
to postpone the commencement of RRT. It should also be 
mentioned that, according to annual reports on RRT, in the 
subsequent years, an increasing percentage of those aged 
75 and more were observed among patients on RRT. This 
could partly result from an increase in the number of kid-
ney transplants in younger age groups and, thus, a percent-
age shift to the older population, but could also be the result 
of an aging society, in general, and the trend toward earlier 
qualification of these patients to RRT [26].
In our study population, a very high prevalence of arte-
rial hypertension was noted. The result was predomi-
nantly dependent on the diagnosis established on the 
basis of declared hypotensive drug intake and, to a lesser 
extent, on the diagnosis established on the basis of blood 
pressure measurements taken. On the one hand, it proves 
wide accessibility of medical services to patients, and on 
the other hand, it raises fear of overdiagnosis—or rather—
excessive AH therapy in old age. It should be remembered 
that therapeutic aims in AH in the population in question 
are much less rigoristic. Current Polish Society on Hyper-
tension guidelines for patients above 80 years of age rec-
ommend a more careful lowering of systolic pressure to a 
level below 150 mmHg [27]. It should be noted that in the 
elderly the standard beneficial role of hypotensive drugs 
may become outweighed in the presence of CKD when 
inappropriately used (fixed combinations of diuretics may 
lead to dehydration, and ACEi/AT1 blockers may result in 
an increase in creatinine concentration).
In people with decreased eGFR, arterial hypertension 
was noted more often than in people with normal kidney 
function. However, unlike in people under 75 years of age, 
logistic regression analysis did not show any significant 
influence of AH on the increased risk of CKD occurrence. 
It was proven, however, that the occurrence of cardiovas-
cular diseases in general definitely increased the risk of 
kidney disease (OR 1.87). It is worth mentioning that in 
the above-mentioned Polnef and Polsenior surveys, it was 
proven that there exists a significant influence of hyperten-
sion on the advancement of CKD. Perhaps, in this case it 
also arises from the analysis of a younger population—
in both surveys a group of people ≥65 years of age was 
observed.
Surprising conclusions arose from the analysis of dia-
betes mellitus (DM) occurrence in the analyzed popula-
tion. Both in people with normal, as well as in those with 
impaired renal function, DM prevalence was comparable 
and similar to that observed in the general elderly popu-
lation. Logistic regression analysis showed that the pres-
ence of DM did not increase the risk of CKD in those 
aged 75+. This surprising occurrence is confirmed by 
the results of other authors. Shastri et al., based on results 
from a survey conducted among American octogenarians, 
also did not confirm the dependency of CKD and DM 
coexistence [17]. It should be added that, according to the 
authors of the NATPOL 2011 survey, DM and diabetic 
kidney disease are the most frequent causes of CKD in the 
general Polish population and the existence of DM triples 
the risk of CKD in people aged 18–79 years [5]. This evi-
dently different epidemiology of this disease in the elderly 
may be drastically explained by the short life expectancy 
of diabetic patients who often do not survive to reach the 
old age. On the other hand, DM observed in the elderly is 
most likely a late-onset disease and, thus, has no substan-
tial influence on the development of CKD. At this point, 
it is worth referring to the PRESAM survey, an epidemi-
ological analysis published several years ago concerning 
the causes of end-stage renal failure [28]. The conclusions 
it reached were clear, that is, while diabetic nephropathy 
was the most common cause of this disease in the popula-
tion between the ages of 45–65, in people above 70 years 
of age vascular nephropathy (defined by both—ischemic 
nephropathy and hypertensive kidney disease) took prior-
ity [29].
Besides the above-mentioned classic risk factors for 
CKD development, attention should also be turned to the 
close relationship between increasing age and the lowering 
of eGFR. Even more interesting seems to be the fact that, 
after attaining 75 years, increasing age no longer becomes 
a significant risk factor for CKD occurrence (OR 1.08). 
Therefore, we can expect that when a given person attains 
the age range in question with proper kidney function, the 
chances for significant deterioration of their function are 
minimal. This emphasizes the need to focus on appropriate 
health-promoting education and encouraging nephroprotec-
tive habits in younger people.
It is worth mentioning that we observed a reverse epi-
demiology for a classic CKD progression risk factor—the 
waist-to-hip ratio (WtHR). The WtHR is used to express and 
measure abdominal obesity [30]. In the analyzed 75+ popu-
lation, it was found that an increase in the WtHR value may 
have a protective role, but only if it was within the normal 
reference range of this index. Such a link was not observed 
for the BMI. This phenomenon can be explained by the fact 
that the higher the WtHR, the lower the chances of cachexia 
or sarcopenia [31]. It needs to be stressed that this does not, 
however, imply that abdominal obesity provides any protec-
tion against CKD, as such a relationship has not been estab-
lished for abnormally high WtHR values. On the contrary, 
in our analysis, the majority of people diagnosed with CKD 
were classified as obese on the basis of increased BMI val-
ues. Probably, what we observed is a similar phenomenon 
to that of patients treated with repeated dialysis, in whom 
reverse epidemiology of these risk factors was observed, in 
terms of their impact on morbidity and mortality [32, 33]. 
It should be pointed out that the existence of a reversed 
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relation in this scope (i.e., WtHR) was also observed in 
elderly people elsewhere [34, 35].
In view of the anticipated methodology provided for in 
the WOBASZ survey of determining creatinine concentra-
tion through Jaffe’s kinetic method, a decision was taken 
to estimate values of eGFR based on the simplified MDRD 
formula (the now commonly used CKD-EPI formula is 
based on the measurement of serum creatinine using the 
enzymatic IDMS traceable technique) [36]. As a result of 
the use of this equation, credible results were obtained for 
the values of eGFR < 60 mL/min/1.73 m2, and this resulted 
in us being able to take into account CKD from the G3a 
stage upwards in our analysis. An additional reason for 
such a choice was the fact that in the outline of this survey 
other markers of kidney damage, e.g., albuminuria, were not 
included. Undoubtedly, this is an undeniable drawback of 
the presented analysis. Nonetheless, by comparing Polnef 
(based primarily on the determination of the level of albu-
minuria) and Polsenior (which used both albuminuria and 
eGFR) surveys, we can go as far as to assume that in the 
analyzed age group the main component of CKD diagnosis 
is the decrease in eGFR, while the occurrence of albuminu-
ria (in contrast to younger age groups) plays a minor role.
We realize that the presented results may have flaws 
typical for population-based cross-sectional studies in this 
field, which stem from the application of the simplified 
definition of CKD, only a single determination of creati-
nine level, and the absence of image studies. However, in 
favor of the presented analysis is a credible methodology of 
sampling of the representative population, a relatively high 
percentage of obtained results, as well as convergence with 
results published by other researchers. Therefore, it should 
be assumed that the presented results show the actual situ-
ation of CKD prevalence in those aged 75 years and above 
in the Polish population.
Conclusion
In the presented work, it was shown that CKD prevalence 
is high in the Polish population aged 75+ and is at 26.9% 
(~495,590 patients), whereas awareness of the disease is rela-
tively low. Both AH as well as increasing age did not essen-
tially increase the risk of CKD in the examined population. It 
was observed, however, that there is a substantial difference, 
in the prevalence of DM among CKD patients, compared to 
that of a younger population. In CKD patients, the prevalence 
of DM was close to that of the general elderly population.
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